Latham & Watkins represented 10X III, while Nelson Mullins Riley & Scarborough represented Sparks Energy in the transaction. Sparks Energy, Inc., a leading provider of power...
10X Capital Venture Acquisition Corp. III’s Merger With Sparks Energy
Binance.US’s Acquisition of Voyager Assets
Latham & Watkins represented Binance.US in the transaction. Voyager Digital Ltd. (OTC Pink VYGVQ; FRA: UCD2) has announced that its operating company Voyager Digital LLC selected...
Razor Group’s Acquisition of Valoreo and Financing Round
Freshfields Bruckhaus Deringer advised Razor Group on the deal. Latham & Watkins advised L Catterton. Hogan Lovells advised VALOREO. Shearman & Sterling advised BlackRock. The transaction...
Deutsche ReGas’ Development of Deutsche Ostsee LNG Terminal
Milbank, Wikborg Rein LLP and Hengeler Mueller advised Deutsche ReGas, while Clifford Chance represented Total Energies. Latham & Watkins advised Worth Capital Holdings Germany LLC (Worth...
Highgate’s Acquisition of Viceroy Hotels & Resorts
Latham & Watkins LLP represented Highgate in the transaction. An affiliate of the Principals of Highgate has announced that it has entered into a definitive agreement...
Madison Dearborn Partners’ Acquisition of M&T Bank’s Wilmington Trust CIT Business
Debevoise & Plimpton advised M&T Bank, while Latham & Watkins and Eversheds Sutherland (US) advised MDP on the deal. M&T Bank Corporation (NYSE: MTB) announced the...
Harps Global’s Acquisition of a Medical Division from Semperit
Schoenherr and Latham & Watkins advised Harps Global on the deal. Harps Global PTE. LTD executed the acquisition of the medical business division (Sempermed) from Austrian...
Terns Pharmaceuticals’ $86 Million Common Stock Offering
Latham & Watkins LLP represented Terns Pharmaceuticals in the offering and Davis Polk advised the underwriters involved. Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
Erasca’s $100 Million Common Stock Offering
Latham & Watkins LLP advised Erasca on the offering. Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies...
Plan B Entertainment’s Partnership with Mediawan
Willkie Farr & Gallagher represented Plan B Entertainment, while Latham & Watkins advised Mediawan in the transaction. Plan B Entertainment, an award-winning production company co-founded and...
The Chefs’ Warehouse’s $250 Million Convertible Senior Notes Offering
Shearman & Sterling represented The Chefs’ Warehouse, while Latham & Watkins represented the initial purchasers in the offering. The Chefs’ Warehouse, Inc. (NASDAQ: CHEF), a premier distributor...
Erasca’s License Agreement With Novartis
Latham & Watkins advised Erasca on the transaction. Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for...